Dr Tony Lim graduated with MBBS from National University of Singapore in 1998. He later then joined the Department of Pathology in Singapore General Hospital and finished his training in 2006, obtaining both FRCPath and FRCPA fellowships. After his HMDP in Liver and Gastrointestinal pathology at Mt Sinai Hospital in New York in 2008, he has returned to practice General Surgical pathology with special interest in Liver and Gastrointestinal Pathology, biliary tract diseases like pancreatobilary cancers and lung cancer. In the years of clinical research setting, he has been involved in numerous clinical trials with pharmaceutical companies and has authored and co-authored numerous publications. Currently, he is the Clinical Director of Personalized OMIC Lattice for Advanced Research and Improving Stratification (POLARIS)@Sing Health, a Sing Health Research Core Platform which utilizes Next Generation Sequencing (NGS) technology to conduct tests and aims to translate novel scientific discoveries into clinically validated assays.